Iradimed Co (IRMD)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $1.09B
Last updated: Nov 17, 2026 at 4:38 PM ET
Iradimed Co (IRMD) Stock Chart
Iradimed (IRMD) has a latest price of $83.45 on Nov 17, 2026, 22.0% below its 52-week high of $106.95. Its price fell 0.1% over the past 12 months. The month-end price rose 711.4% over the 10 years through Oct 2026, a compound annual rate of 23.3%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $103.53 in Feb 2026 and its lowest $8.15 in May 2017, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart IRMD with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for IRMD.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 4.3%, and over 6 months it fell 4.3%. The month-end price rose 88.2% over the 3 years through Oct 2026, a compound annual rate of 23.5%.
| Period | Change |
|---|---|
| 1 month | -4.6% |
| 3 months | -4.3% |
| 6 months | -4.3% |
| 12 months | -0.1% |
| 12 months, with dividends | +1.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +88.2% | +23.5% |
| 5 years | +105.5% | +15.5% |
| 10 years | +711.4% | +23.3% |
Price by Year
Its best calendar year was 2021, when the price rose 102.7%, and its weakest was 2022, when it fell 38.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $76.68 | -21.2% |
| 2025 | $97.28 | +76.9% |
| 2024 | $55.00 | +15.9% |
| 2023 | $47.47 | +67.8% |
| 2022 | $28.29 | -38.8% |
| 2021 | $46.21 | +102.7% |
| 2020 | $22.80 | -2.5% |
| 2019 | $23.38 | -4.4% |
| 2018 | $24.46 | +61.5% |
| 2017 | $15.15 | +36.5% |
Trading Range
The price is 2.0% below its 50-day average of $85.12 and 8.6% below its 200-day average of $91.30.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $83.45 | |
| 52-week high | $106.95 | -22.0% |
| 52-week low | $76.17 | +9.6% |
| 50-day average | $85.12 | -2.0% |
| 200-day average | $91.30 | -8.6% |
Price Risk
Over 3 years, its largest fall from a peak was 27.1%.
| Measure | Value |
|---|---|
| 1-year beta | 0.73 |
| Largest fall, 1 year | -27.1% |
| Largest fall, 3 years | -27.1% |
Valuation
Iradimed traded at 50.7x earnings at the end of 2025, against a 5-year median of 34.6x and a 10-year median of 35.7x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About IRMD
What is IRMD's 1-year price change?
Iradimed's price fell 0.1% over the past 12 months. With dividends included, the 12-month total return was 1.4%.
What is IRMD's 5-year price change?
Iradimed's month-end price rose 105.5% over the 5 years through Oct 2026, a compound annual rate of 15.5%. These figures leave out dividends.
What is IRMD's 52-week high and low?
Iradimed's 52-week high is $106.95 and its 52-week low is $76.17. Its latest price of $83.45 on Nov 17, 2026 is 22.0% below the high.
What is IRMD's beta?
Iradimed's 1-year beta against the S&P 500 is 0.73, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 27.1%.
Is the IRMD chart free?
Yes. Advanced Charting for IRMD is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
IRMD pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts